Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 6 pages · Chinese
Yabao Pharmaceutical Group Co. Ltd. has announced a share repurchase plan through a call auction, detailing the purpose and procedures for the buyback. The plan aims to repurchase shares to enhance shareholder value and will utilize the company's own funds, with a specified price limit for the shares. The repurchase is subject to approval by the company's shareholders and is expected to be completed within a year after approval. The filing also outlines potential risks associated with the buyback, including the need for creditor consent and market conditions affecting the share price.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Yabao Pharmaceutical Group Co. Ltd. on 6ix
Follow Yabao Pharmaceutical into a list and get an email when it puts out news.
Follow Yabao Pharmaceutical